Service
Preclinical services to accelerate drug development
Our mission is to be your partner of choice for preclinical services that expedite drug development processes.
CEO
IVRS
Lund, Sweden
Prof. at Lund Univ. Sweden and founder of the company IVRS, focusing on oncology and preclinical imaging.
Dr. Ramin Massoumi is a Professor and Principal Investigator at Lund University, Sweden. After earning a PhD from Lund University and completing postdoctoral training at the Max Planck Inst. for Biochemistry in Germany, Dr. Massoumi now leads a research group focused on cancer biology and the development of novel anticancer drugs. As the founder of the Company IVRS, Dr. Massoumi contributes to cancer research both academically and commercially.
My organisation
IVRS: Pioneering Preclinical CRO for Accelerating Drug Discovery
IVRS is a cutting-edge preclinical contract research organization (CRO) focused on advancing drug discovery and validation for severe human diseases with critical unmet medical needs.
Our comprehensive expertise in both in vitro and in vivo models spans cancer, neurodegenerative diseases, and inflammatory disorders, positioning us to fast-track the development of life-changing therapies.
We specialize in monitoring disease progression and treatment efficacy over time in living animal models through advanced imaging technologies. Our deep-tissue and whole-body 3D imaging capabilities provide real-time insights, allowing for the precise tracking of individual variations. This enables the design of safer, more effective therapies, ultimately bringing innovative solutions to clinical studies.
Service
Preclinical services to accelerate drug development
Our mission is to be your partner of choice for preclinical services that expedite drug development processes.
Partnership
Developing novel imaging techniques
Collaboration on developing novel imaging probes and techniques.
Project cooperation
Disease progression imaging techniques
Collaboration on grant applications to secure funding for innovative projects.
Expertise
Preclinical services to accelerate drug development
Research partner for preclinical services aimed at accelerating drug development.